Roman Necina
Geschäftsführer bei HOOKIPA PHARMA INC.
Vermögen: 11 990 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Jörn Aldag | M | 65 | 8 Jahre | |
| Jan van de Winkel | M | 63 | 7 Jahre | |
| Reinhard Kandera | M | 54 | 7 Jahre | |
| Julie O'Neill | F | 58 | 6 Jahre | |
| Mary Coelho | F | 62 | 1 Jahre | |
| Tony Melckenbeek | M | - | - | |
| Klaus Orlinger | M | 46 | 12 Jahre | |
| David Kaufman | M | 51 | 5 Jahre | |
| Timothy Reilly | M | 50 | 2 Jahre | |
| Norbert Riedel | M | 66 |
Austrian Academy of Sciences
 Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | 15 Jahre |
| Victor Paulus | M | - | 6 Jahre | |
| Karin Schaupp | M | 74 |
Austrian Academy of Sciences
Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | - |
| Malte Peters | M | 61 | 1 Jahre | |
| Monika Henzinger | M | 58 |
Austrian Academy of Sciences
Austrian Academy of Sciences Miscellaneous Commercial ServicesCommercial Services The Austrian Academy of Sciences provides humanities and social science research services. The private company is based in Vienna, Austria. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Michael Kelly | M | 67 | 4 Jahre | |
| Daniel D. Pinschewer | M | 49 | 8 Jahre | |
| Christine D. Baker | F | 58 | 5 Jahre | |
| Jean-Charles Soria | M | 53 | - | |
| Christoph S. Lengauer | M | 59 | 4 Jahre | |
| Katia Schlienger | M | 62 | 2 Jahre | |
| Graziano Seghezzi | M | 55 | 10 Jahre | |
| Sander J. van Deventer | M | 69 | 9 Jahre | |
| Thomas D. Szucs | M | 64 |
Intercell AG
 Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 Jahre |
| Anders Lilja | M | - | 7 Jahre | |
| Gerd Zettlmeissl | M | 68 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 10 Jahre |
| Werner Lanthaler | M | 56 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 9 Jahre |
| David Ebsworth | M | 69 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 8 Jahre |
| Katherine Cohen | M | - |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 11 Jahre |
| Matthew Beck | M | - | 4 Jahre | |
| Gregory Glenn | M | 70 |
Intercell AG
Intercell AG Pharmaceuticals: MajorHealth Technology Intercell AG engages in the research, development, manufacture, and marketing of novel vaccines for the prevention and treatment of infectious diseases. Its products include Japanese encephalitis vaccine, Pseudomonas vaccine, Clostridium difficile vaccine, tuberculosis vaccine, and pandemic influenza vaccine patch. Its technology platforms involve patch-based delivery system and proprietary human monoclonal antibody discovery system. The company was founded by Alexander von Gabain, Max Birnstiel, Michael Buschle, Walter Schmidt, and Aaron Hirsh on December 3, 1997 and is headquartered in Vienna, Austria. | 2 Jahre |
| Igor Matushansky | M | 51 | 5 Jahre | |
| Gwenaelle Kerforn | F | - | 3 Jahre | |
| Nina Waibel | F | - | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 24 | 72,73% |
| Österreich | 9 | 27,27% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Roman Necina
- Persönliches Netzwerk
